Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

NCT ID: NCT06616753

Last Updated: 2025-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-16

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are:

* the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital
* hospitalized patients' attitude to vaccination in general. Evaluate the number of patients wishing to update their vaccination status. Observe the influence of various factors (gender, occupation, presence or absence of GP, chronic illness) on vaccination status in Melun, France Participants will be asked to complete a questionnaire during hospitalization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we are asking a sample of patients hospitalized in our hospital to complete a questionnaire on their knowledge of their vaccination status, and to assess their relationship with vaccination.

Questionnaire administered to patient during hospitalization (n=140 patients). Patients randomly selected by the Department of Medical Information of the hospital at the beginning of the survey week.

Patients randomly selected from each of the 10 departments of the CH of Melun (internal medicine, infectious diseases, gastroenterology, pneumology, surgery, BCR medicine, cardiology, nephrology, follow-up care and rehabilitation and geriatrics) and accompanied to complete a questionnaire set up by the Public Health Unit (USP) and Hygiene Operational Team (EOH) of the CH of Melun.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccinia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vaccination status

knowledge of own vaccination status

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* French-speaking and non-demented patient : able to speak and understand French and without dementia
* Adult patient (Age ≥ 18 years)
* Main place of residence in France
* Hospitalized in a department of the CH of Melun

Exclusion Criteria

* Does not speak French or dementia
* Patient's refusal to participate in the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Hospitalier Sud Ile-de-France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

CORALIE NOEL

Role: PRINCIPAL_INVESTIGATOR

Groupe Hospitalier Sud Ile-de-France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Groupe Hospitalier Sud Ïle de France

Melun, Seine Et Marne, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CORALIE NOEL

Role: CONTACT

0033181742127

AGHER AREZKI

Role: CONTACT

0033181742228

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

AGHER AREZKI

Role: primary

+33181742228

FAYALI TAKOUA

Role: backup

0033181742774

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01028-37

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ARISe at UMass Chan
NCT07236034 RECRUITING NA